Major neurotransmitters involved in the regulation of sleep-wake cycle;Principales neurotransmisores involucrados en la regulación del ciclo sueño-vigilia

Revista de Investigacion Clinica

Volumn 64, Issue 2, 2012, Pages 182-191

  Franco Pérez, Javier ^a,b   Ballesteros Zebadúa, Paola ^a   Custodio, Verónica ^a   Paz, Carlos ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acetylcholine; Adenosine; GABA; Histamine; Noradrenaline; Orexins; Serotonin; Sleep; Wakefulness

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; HISTAMINE; NEUROTRANSMITTER; NORADRENALIN; OREXIN; SEROTONIN;

BRAIN REGION; BRAIN STEM; ELECTROPHYSIOLOGY; HYPOTHALAMUS; REGULATORY MECHANISM; REVIEW; SLEEP WAKING CYCLE; WAKEFULNESS;

HUMANS; NEUROTRANSMITTER AGENTS; SLEEP; WAKEFULNESS;

EID: 84866271895     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Aserinsky E, Kleitman N. Regularly occurring periods of eye motility and concomitant phenomena during sleep. Science 1953; 118: 273-4.
2. García-García F, Acosta-Peña E, Venebra-Muñoz A, Murillo-Rodríguez E. Sleep-inducing factors. CNS Neurol Disord Drug Targets 2009; 8: 235-44.
3. Lee SB, Beak SK, Park SH, Waterhouse BD, Lee HS. Collateral projection from the locus coeruleus to whisker-related sensory and motor brain regions of the rat. J Comp Neurol 2009; 514: 387-402.
4. Sharma Y, Xu T, Graf WM, Fobbs A, Sherwood CC, Hof PR, et al. Comparative anatomy of the locus coeruleus in humans and nonhuman primates. J Comp Neurol 2010; 518: 963-71.
5. Aston-Jones G, Bloom F. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981; 1: 876-86.
6. Takahashi K, Kayama Y, Lin JS, Sakai K. Locus coeruleus neuronal activity during the sleep-waking cycle in mice. Neuroscience 2010; 169: 1115-26.
7. Berridge CW, Stellick R, Schmeichel B. Wake-promoting actions of medial basal forebrain beta2 receptor stimulation. Behav Neurosci 2005; 119: 743-51.
8. Berridge CW. Noradrenergic modulation of arousal. Brain Res Rev 2008; 58: 1-17.
9. Berridge CW, España R. Synergistic sedative effects of noradrenergic alpha (1) and beta-receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience 2000; 99: 495-505.
10. Pal D, Mallick BN. Role of noradrenergic and GABA-ergic inputs in pedunculopontine tegmentum for regulation of rapid eye movement sleep in rats. Neuropharmacology 2006; 51: 1-11.
11. Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs 2008; 68: 1803-39.
12. Jouvet M. Biogenic amines and the states of sleep. Science 1969; 163: 32-41.
13. Urbain N, Creamer K, Debonnel G. Electrophysiological diversity of the dorsal raphe cells across the sleep-wake cycle of the rat. J Physiol 2006; 573: 679-95.
14. Monti JM. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. Sleep Med Rev 2010; 14: 319-27.
15. Dzoljic M, Ukponmwan O, Saxena P. 5-HT1-like receptor agonists enhance wakefulness. Neuropharmacology 1992; 31: 623-33.
16. Tejada S, Rial RV, Gamundí A, Esteban S. Effects of serotonergic drugs on locomotor activity and vigilance states in ring doves. Behav Brain Res 2011; 216: 238-46.
17. Monti JM, Jantos H, Lagos P. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat. Behav Brain Res 2010; 206: 8-16.
18. Monti JM, Leopoldo M, Jantos H. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav Brain Res 2008; 191: 184-9.
19. Monti JM, Jantos H. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 940-7.
20. Kantor S, Jakus S, Bodizs R, Halasz P, Bagdy G. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity and sleep: changes at the light-dark phase shift. Brain Res 2002; 943: 105-11.
21. Morairty SR, Hedley L, Flores J, Martin R, Kilduff TS. Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats. Sleep 2008; 31: 34-44.
22. Descamps A, Rousset C, Millan MJ, Spedding M, Delagrange P, Cespuglio R. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture. Psychopharmacology 2009; 205: 93-106.
23. Boothman L, Raley J, Denk F, Hirani E, Sharp T. In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol 2006; 149: 861-9.
24. Liu R, van den Pol A, Aghajanian G. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 2002; 22: 9453-64.
25. Steriade M, Datta S, Pare D, Oakson G, Curro R. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J Neurosci 1990; 10: 2541-59.
26. Hassani OK, Lee MG, Henny P, Jones BE. Discharge profiles of identified GABAergic in comparison to cholinergic and putative glutamatergic basal forebrain neurons across the sleep-wake cycle. J Neurosci 2009; 29: 11828-40.
27. Marrosu F, Portas C, Mascia M, Casu M, Fa M, Giagheddu M, et al. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res 1995; 671: 329-32.
28. Vazquez J, Baghdoyan HA. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. Am J Physiol Regul Integr Comp Physiol 2001; 280: R598-R601.
29. Ishida T, Kamei C. Characteristic effects of anti-dementia drugs on rat sleep patterns. J Pharmacol Sci 2009; 109: 449-55.
30. Coleman C, Lydic R, Baghdoyan H. M2 muscarinic receptors in pontine reticular formation of C57BL/6J mouse contribute to rapid eye movement sleep generation. Neuroscience 2004; 126: 821-30.
31. Marks G, Birabil C. Carbachol induction of REM sleep in the rat is more effective at lights-out than lights-on. Brain Res 2007; 1142: 127-34.
32. Fenik VB, Kubin L. Differential localization of carbachol- and bi-cuculline-sensitive pontine sites for eliciting REM sleep-like effects in anesthetized rats. J Sleep Res 2008; 18: 99-112.
33. Velazquez-Moctezuma J, Shalauta MD, Gillin JC, Shiromani PJ. Microinjections of nicotine in the medial pontine reticular formation elicits REM sleep. Neurosci Lett 1990; 115: 265-8.
34. Vázquez-Palacios G, Hernández-González M, Guevara-Pérez MA, Bonilla-Jaime H. Nicotine and fluoxetine induce arousing effects on sleep-wake cycle in antidepressive doses: a possible mechanism of antidepressant-like effects of nicotine. Pharmacol Biochem Behav 2010; 94: 503-9.
35. Fuller PM, Saper CB, Lu J. The pontine REM switch: past and present. J Physiol 2007; 584: 735-41.
36. Vetrivelan R, Fuller PM, Tong Q, Lu J. Medullary circuitry regulating rapid eye movement sleep and motor atonia. J Neurosci 2009; 29: 9361-9.
37. Szymusiak R, Alam N, Steininger TL, McGinty D. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998; 803: 178-88.
38. Suntsova N, Szymusiak R, Alam MN, Guzman-Marin R, McGinty D. Sleep-waking discharge patterns of median preoptic nucleus neurons in rats. J Physiol 2002; 543: 665-77.
39. Suntsova N, Guzman-Marin R, Kumar S, Alam MN, Szymusiak R, McGinty D. The median preoptic nucleus reciprocally modulates activity of arousal-related and sleep-related neurons in the perifornical lateral hypothalamus. J Neurosci 2007; 27: 1616-30.
40. Szymusiak R, McGinty D. Hypothalamic regulation of sleep and arousal. Ann N Y Acad Sci 2008; 1129: 275-86.
41. Hirase M, Ishida T, Kamei C. Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats. Eur J Pharmacol 2008; 597: 46-50.
42. Passarella S, Doung MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm 2008; 65: 927-34.
43. Xi M, Chase MH. Effects of eszopiclone and Zolpidem on sleep and waking states in the adult guinea pig. Sleep 2008; 31: 1043-51.
44. Nutt DJ, Stahl SM. Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol 2010; 24: 1601-12.
45. Lancei M, Grönlein T, Faulhaber J. Role of GABAA receptors in sleep regulation. Differential effects of muscimol and midazolam on sleep in rats. Neuropsychopharmacology 1996; 15: 63-74.
46. Alexandre C, Dordal A, Aixendri R, Guzman A, Hamon M, Adrien J. Sleep-stabilizing effects of E-6199, compared to zopiclone, Zolpidem and THIP in mice. Sleep 2008; 31: 259-70.
47. Thakkar MM, Winston S, McCarley RW. Effect of microdialysis perfusion of 4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridine-3-ol in the perifornical hypothalamus on sleep-wakefulness: role of delta-subunit containing extrasynaptic GABAA receptors. Neuroscience 2008; 153: 551-5.
48. Deschaux O, Froestl W, Gottesmann C. Influence of a GABA(B) and GABA(C) receptor antagonist on sleep-waking cycle in the rat. Eur J Pharmacol 2006; 535: 177-81.
49. Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, et al. Distribution of histaminergic system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984; 295: 13-25.
50. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008; 88: 1183-241.
51. Takahashi K, Lin JS, Sakai K. Neuronal activity of histaminergic tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci 2006; 26: 10292-8.
52. Sakai K, Takahashi K, Anaclet C, Lin JS. Sleep-waking discharge of ventral tuberomammillary neurons in wild-type and histidine decarboxylase knock-out mice. Front Behav Neurosci 2010; 4: 53.
53. Monti J, Pellejero T, Jantos H. Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat. J Neural Transm 1986; 66: 1-11.
54. Ramesh V, Thakkar M, Strecker R, Basheer R, McCarley R. Wakefulness-inducing effects of histamine in the basal forebrain of freely moving rats. Behav Brain Res 2004; 152: 271-8.
55. Tokunaga S, Takeda Y, Shinomiya K, Hirase M, Kamei C. Effects of Some H1-Antagonists on the Sleep-Wake Cycle in Sleep-Disturbed Rats. J Pharmacol Sci 2007; 103: 201-6.
56. Tokunaga S, Tsutsui R, Obara Y, Ishida T, Kamei C. Effects of histamine H1-antagonists on sleep-awake state in rats placed on a grid suspended over water or on sawdust. Biol Pharm Bull 2009; 32: 51-4.
57. Lin JS, Sergeeva OA, Haas HL. Histamine H3 receptors and sleep-wake regulation. J Pharmacol Exp Ther 2011; 336: 17-23.
58. Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, et al. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem Pharmacol 2007; 73: 1157-71.
59. De Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. PNAS 1998; 95: 322-7.
60. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli R, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
61. Stoyanova I, Rutten WL, le Feber J. Orexin-A and orexin-B during the postnatal development of the rat brain. Cell Mol Neurobiol 2010; 30: 81-9.
62. Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinal 2008; 29: 70-87.
63. Lee M, Hassani O, Jones B. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005; 25: 6716-20.
64. Takahashi K, Lin JS, Sakai K. Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse. Neuroscience 2008; 153: 860-70.
65. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-76.
66. Mishima K, Fujiki N, Yoshida Y, Sakurai T, Honda M, Mignot E, et al. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep 2008; 31: 1119-26.
67. Thannickal T, Moore R, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-74.
68. Thannickal T, Nienhuis R, Siegel J. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 2009; 32: 993-8.
69. Hagan J, Leslie R, Patel S, Evans M, Wattam T, Holmes S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. PNAS 1999; 96: 10911-6.
70. Akanmu M, Honda K. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats. Brain Res 2005; 1048: 135-45.
71. Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, et al. Promotion of sleep by targeting the orexin system in rats, dogs, and humans. Nat Med 2007; 13: 150-5.
72. Porkka-Heiskanen T, Strecker R, McCarley R. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 2000; 99: 507-17.
73. McKenna J, Tartar J, Ward C, Thakkar M, Cordeira J, McCarley R, et al. Sleep fragmentation elevates behavioral, electrographic and neurochemical measures of sleepiness. Neuroscience 2007; 146: 1462-73.
74. Schwierin B, Borbély A, Tobler I. Effects of N- cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 1996; 300: 163-71.
75. Okuro M, Fujiki N, Kotorii N, Ishimaru Y, Sokoloff P, Nishino S. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Sleep 2010; 33: 930-42.
76. Thakkar M, Engemann S, Walsh K, Sahota P. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 2008; 153: 875-80.
77. Portas C, Thakkar M, Rainnie D, Greene R, McCarley R. Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience 1997; 79: 225-35.
78. Oishi Y, Huang Z, Fredholm B, Urade Y, Hayaishi O. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. PNAS 2008; 105: 19992-7.
79. Franco-Pérez J, Paz C. Quinine, a selective gap junction blocker, decreases REM sleep in rats. Pharmacol Biochem Behav 2009; 94: 250-4.
80. Saper C, Fuller P, Pedersen N, Lu J, Scammell T. Sleep state switching. Neuron 2010; 68: 1023-42.
81. Hobson J, McCarley R, Wyzinsky P. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975; 189: 55-8.
82. Lu J, Sherman D, Devor M, Saper C. A putative flip-flop switch for control on REM sleep. Nature 2006; 441: 589-94.